Clinical Trial

PK and Onset of Hezkue Oral Sildenafil Suspension After Alcohol Consumption

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated December 24, 2025 (before its estimated May 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is an open-label, randomized study evaluating the pharmacokinetics and onset performance of Hezkue® oral sildenafil suspension administered following moderate alcohol consumption in healthy adult subjects. Participants will receive Hezkue® under controlled alcohol-exposure conditions. Pharmacokinetic sampling, onset assessments, and safety evaluations will be conducted throughout the study.
Trial Details
NCT Number NCT07302698
Lead Sponsor Aspargo Labs, Inc
Conditions Healthy Volunteers
Enrollment 24 participants
Start Date 2026-03-15
Primary Completion 2026-05-15 (estimated)
Study Completion 2026-05-28 (estimated)
Updated on ClinicalTrials.gov 2025-12-24